Literature DB >> 24797212

Radiation sensitivity of human and murine peripheral blood lymphocytes, stem and progenitor cells.

Daniel Heylmann1, Franz Rödel2, Thomas Kindler3, Bernd Kaina4.   

Abstract

Immunodeficiency is a severe side effect of radiation therapy, notably at high radiation doses. It may also impact healthy individuals exposed to environmental ionizing radiation. Although it is believed to result from cytotoxicity of bone marrow cells and of immunocompetent cells in the peripheral blood, the response of distinct bone marrow and blood cell subpopulations following exposure to ionizing radiation is not yet fully explored. In this review, we aim to compile the knowledge on radiation sensitivity of immunocompetent cells and to summarize data from bone marrow and peripheral blood cells derived from mouse and human origin. In addition, we address the radiation response of blood stem and progenitor cells. The data indicate that stem cells, T helper cells, cytotoxic T cells, monocytes, neutrophils and, at a high degree, B cells display a radiation sensitive phenotype while regulatory T cells, macrophages, dendritic cells and natural killer cells appear to be more radioresistant. No conclusive data are available for basophil and eosinophil granulocytes. Erythrocytes and thrombocytes, but not their precursors, seem to be highly radioresistant. Overall, the data indicate considerable differences in radiosensitivity of bone marrow and blood normal and malignant cell populations, which are discussed in the light of differential radiation responses resulting in hematotoxicity and related clinical implications.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer therapy; DNA repair; Lymphocytes; Monocytes; Radiation; Stem cells

Mesh:

Year:  2014        PMID: 24797212     DOI: 10.1016/j.bbcan.2014.04.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  74 in total

Review 1.  Dying to protect: cell death and the control of T-cell homeostasis.

Authors:  Kun-Po Li; Sharmila Shanmuganad; Kaitlin Carroll; Jonathan D Katz; Michael B Jordan; David A Hildeman
Journal:  Immunol Rev       Date:  2017-05       Impact factor: 12.988

2.  Manipulating DNA damage-response signaling for the treatment of immune-mediated diseases.

Authors:  Jonathan P McNally; Scott H Millen; Vandana Chaturvedi; Nora Lakes; Catherine E Terrell; Eileen E Elfers; Kaitlin R Carroll; Simon P Hogan; Paul R Andreassen; Julie Kanter; Carl E Allen; Michael M Henry; Jay N Greenberg; Stephan Ladisch; Michelle L Hermiston; Michael Joyce; David A Hildeman; Jonathan D Katz; Michael B Jordan
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-22       Impact factor: 11.205

3.  p53 Hinders CRISPR/Cas9-Mediated Targeted Gene Disruption in Memory CD8 T Cells In Vivo.

Authors:  Samarchith P Kurup; Steven J Moioffer; Lecia L Pewe; John T Harty
Journal:  J Immunol       Date:  2020-09-04       Impact factor: 5.422

4.  Long-Lasting Impact of Neonatal Exposure to Total Body Gamma Radiation on Secondary Lymphoid Organ Structure and Function.

Authors:  Javier Rangel-Moreno; Maria de la Luz Garcia-Hernandez; Rosalio Ramos-Payan; Jamie Biear; Eric Hernady; Mark Y Sangster; Troy D Randall; Carl J Johnston; Jacob N Finkelstein; Jacqueline P Williams
Journal:  Radiat Res       Date:  2015-09-23       Impact factor: 2.841

5.  Wiskott-Aldrich syndrome protein senses irradiation-induced DNA damage to coordinate the cell-protective Golgi dispersal response in human T and B lymphocytes.

Authors:  Kuo-Kuang Wen; Seong-Su Han; Yatin M Vyas
Journal:  J Allergy Clin Immunol       Date:  2019-10-09       Impact factor: 10.793

Review 6.  Exploring the rationale for combining ionizing radiation and immune checkpoint blockade in head and neck cancer.

Authors:  Megan Morisada; Michael Chamberlin; Clint Allen
Journal:  Head Neck       Date:  2018-02-20       Impact factor: 3.147

7.  Lack of viral control and development of combination antiretroviral therapy escape mutations in macaques after bone marrow transplantation.

Authors:  Christopher W Peterson; Kevin G Haworth; Patricia Polacino; Meei-Li Huang; Craig Sykes; Willimark M Obenza; Andrea C Repetto; Angela Kashuba; Roger Bumgarner; Stephen C DeRosa; Ann E Woolfrey; Keith R Jerome; James I Mullins; Shiu-Lok Hu; Hans-Peter Kiem
Journal:  AIDS       Date:  2015-08-24       Impact factor: 4.177

Review 8.  Immune modulatory effects of radiotherapy as basis for well-reasoned radioimmunotherapies.

Authors:  Michael Rückert; Lisa Deloch; Rainer Fietkau; Benjamin Frey; Markus Hecht; Udo S Gaipl
Journal:  Strahlenther Onkol       Date:  2018-03-02       Impact factor: 3.621

Review 9.  The melatonin immunomodulatory actions in radiotherapy.

Authors:  M Najafi; A Shirazi; E Motevaseli; Gh Geraily; F Norouzi; M Heidari; S Rezapoor
Journal:  Biophys Rev       Date:  2017-03-27

10.  PD-1 blockade reverses adaptive immune resistance induced by high-dose hypofractionated but not low-dose daily fractionated radiation.

Authors:  Megan Morisada; Paul E Clavijo; Ellen Moore; Lillian Sun; Michael Chamberlin; Carter Van Waes; James W Hodge; James B Mitchell; Jay Friedman; Clint T Allen
Journal:  Oncoimmunology       Date:  2017-11-27       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.